keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Zinc Protoporphyrin (Zn(II)-protoporphyrin IX) 是一种具有口服活性的,竞争性血红素加氧酶-1 抑制剂,显著减弱间苯三酚对 H2O2 的保护作用,具有抗癌活性。它用于评估人群铁状态与血红蛋白浓度的组合,也可用作个体孕妇和儿童缺铁的筛查标志物。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 538 | 现货 | ||
5 mg | ¥ 1,970 | 现货 | ||
10 mg | ¥ 2,990 | 现货 | ||
25 mg | ¥ 4,520 | 现货 | ||
50 mg | ¥ 6,430 | 现货 | ||
100 mg | ¥ 8,780 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 2,730 | 现货 |
产品描述 | Zinc Protoporphyrin (Zn(II)-protoporphyrin IX) is an orally active and competitive inhibitor of heme oxygenase-1 (HO-1) and markedly attenuates the protective effects of Phloroglucinol (PG) against H2O2, and has anti-cancer activity. |
体外活性 | Protoporphyrin zinc (Zn(II)-protoporphyrin IX; 5 μM; 72 hours) increased the proportion of late apoptosis and necrotic cells from 10.9% in the control group to 30.4% after 72 hours [3]. Zinc Protoporphyrin (1.25-40 μM; 48 or 72 hours) exerts cystostatic/cytotoxic effects against tumor cells[3]. Zinc Protoporphyrin (2.5, 5 μM; 48 or 72 hours) results in dose- and time-dependent reduction of cells in G1 phase of the cell cycle[3]. Zinc Protoporphyrin (1.25-40 μM; 48 hours) leads to accumulation of cleaved (active) caspase-3[3]. |
体内活性 | Zinc Protoporphyrin exhibits dose-dependent antitumor effects manifested by the retardation of tumor growth[3]. |
别名 | Zinc Protoporphyrin-9, 锌原卟啉, ZnPP, Zn(II)-protoporphyrin IX |
化合物与蛋白结合的复合物 |
Escherichia coli Bacterioferritin Substituted with Zinc Protoporphyrin IX |
分子量 | 626.02 |
分子式 | C34H32N4O4Zn |
CAS No. | 15442-64-5 |
keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (79.87 mM), Sonication is recommended.
H2O: < 0.1 mg/mL (insoluble)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.5974 mL | 7.987 mL | 15.9739 mL | 39.9348 mL |
5 mM | 0.3195 mL | 1.5974 mL | 3.1948 mL | 7.987 mL | |
10 mM | 0.1597 mL | 0.7987 mL | 1.5974 mL | 3.9935 mL | |
20 mM | 0.0799 mL | 0.3993 mL | 0.7987 mL | 1.9967 mL | |
50 mM | 0.0319 mL | 0.1597 mL | 0.3195 mL | 0.7987 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Zinc Protoporphyrin 15442-64-5 Apoptosis Immunology/Inflammation Metabolism NF-Κb Reactive Oxygen Species Endogenous Metabolite screening Zinc Protoporphyrin9 heme Zinc Protoporphyrin-9 iron inhibit Phloroglucinol deficiency,anti-cancer 锌原卟啉 Inhibitor marker ZnPP H2O2 Zn(II)-protoporphyrin IX HO-1 oxygenase-1 Zinc Protoporphyrin 9 inhibitor